Healthcare Equipment and Supplies
Company Overview of CooperVision, Inc.
CooperVision, Inc. designs and manufactures eye contact lenses and related products. It offers monthly, two-week, and daily disposable silicone hydrogel contact lenses for patients with astigmatism, nearsightedness, farsightedness, presbyopia, and more. The company also offers spherical, toric, and multifocal products. It sells its products to customers in the United States and internationally. The company was founded in 1979 and is based in Fairport, New York with regional locations in the Americas, Europe, the Asia Pacific, Africa, and Central Eurasia. CooperVision, Inc. operates as a subsidiary of The Cooper Companies Inc.
370 Woodcliff Drive
Fairport, NY 14450
Founded in 1979
Key Executives for CooperVision, Inc.
President and Chief Operating Officer
Chief Financial Officer and Vice President
Senior Vice President of Global Professional & Clinical Affairs
Global Managing Director of International Accounts
Vice President of Global Marketing
Compensation as of Fiscal Year 2015.
CooperVision, Inc. Key Developments
EP Global Communications, Inc. Reaches Settlement Agreement with CooperVision, Inc
Jan 7 16
EP Global Communications, Inc. executed a Settlement Agreement with CooperVision Inc. on December 31, 2015. In 2014, the two Companies worked together to jointly develop advanced contact lens technology concepts. On December 31, 2015 the parties executed a Settlement Agreement setting the parties' respective rights in the jointly filed patent applications and allowing each party to separately and independently pursue these contact lens concepts. The settlement also addresses the ongoing prosecution of several related joint patent applications. CooperVision is to pay EPGL an undisclosed cash component and will retain certain rights to use the technologies disclosed in the jointly filed patent applications to develop and commercialize contact lenses and relinquish all rights to other patent applications filed by EPGL. In exchange, EPGL gains sole ownership and control of the jointly filed patent applications and unlimited worldwide marketing right to license the technologies disclosed in the jointly filed patent applications to all other manufacturers and partners worldwide. EPGL will earn 100% of all future revenues from such potential deals going forward.
CooperVision Announces Earnings Results for the Fourth Quarter of 2015; Provides Earnings Guidance for the First Quarter and Full Year of 2016
Dec 3 15
CooperVision announced earnings results for the fourth quarter of 2015. For the quarter, the company reported revenues of $373 million, down 3% year-over-year but up 5% in constant currency and up 7% in constant currency, excluding solutions. Non-GAAP operating income and margin were $100.2 million and 26.8% of revenue versus $98 million and 25.4% of revenue in the prior year.
For the fiscal 2016, the company expects revenue range is $1.509 billion to $1.539 billion or 5% to 7% constant-currency growth.
For the first quarter of fiscal 2016, the company expects revenues in the $356 million to $366 million range or 3% to 5% constant-currency growth.
CooperVision to Invest USD 40 Million into Hungary Unit
Jul 13 15
CooperVision is to invest USD 40 million over the next three years at its unit in Gyal, near Budapest. The investment will create 400 jobs.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|